Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Jennifer A. Farmer"'
Autor:
Christian Rummey, Theresa A. Zesiewicz, Santiago Perez‐Lloret, Jennifer M. Farmer, Massimo Pandolfo, David R. Lynch
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 7, Iss 9, Pp 1708-1712 (2020)
Abstract The modified Friedreich Ataxia Rating Scale (mFARS) is a disease specific, exam‐based neurological rating scale commonly used as a outcome measure in clinical trials. While extensive clinimetric testing indicates it’s validity in measuri
Externí odkaz:
https://doaj.org/article/a0b6ae74147544edba099c849dee977f
Publikováno v:
EClinicalMedicine, Vol 18, Iss , Pp - (2020)
Background: Friedreich's ataxia (FRDA) is a characterized by progressive loss of coordination and balance leading to loss of ambulation (LoA) in nearly all affected individuals. While transition to becoming fully wheelchair bound is a critical milest
Externí odkaz:
https://doaj.org/article/06b6837b776446ed8ce857743c78e819
Autor:
Sarah C Milne, Geneieve Tai, Ritchie Malapira, Jessica D. Shaw, Martin B. Delatycki, Mary Danoudis, Eppie M. Yiu, Jennifer M. Farmer, Fatemeh Rasouli, Louise A. Corben, Nellie Georgiou-Karistianis, Tyagi Ramakrishnan, Seok Hun Kim, Jane Larkindale, Anna Murphy, Theresa A. Zesiewicz
Publikováno v:
Cerebellum (London, England). 21(6)
To identify gait and balance measures that are responsive to change during the timeline of a clinical trial in Friedreich ataxia (FRDA), we administered a battery of potential measures three times over a 12-month period. Sixty-one ambulant individual
Autor:
Ashley McCormick, Martin B. Delatycki, Joseph Chad Hoyle, Jaclyn Tamaroff, Kimberly Y. Lin, Jonathan A. Mitchell, Maya Patel, Manuela Corti, Jennifer M. Farmer, Christian Rummey, Susan Perlman, S Subramony, Theresa A. Zesiewicz, David A. Lynch, Grace Yoon, George Wilmot, Katherine D. Mathews, Julia Dunn, Shana E. McCormack
Publikováno v:
Neurology: Genetics
article-version (Version of Record) 3
article-version (Version of Record) 3
Background and ObjectivesBody mass index (BMI) and height are important indices of health. We tested the association between these outcomes and clinical characteristics in Friedreich ataxia (FRDA), a progressive neuromuscular disorder.MethodsParticip
Autor:
Daenuka Muraleetharan, Christi N. Hays, Whitney R. Garney, Kristen Garcia, Jennifer L. Farmer, Kelly L. Wilson, Kenneth R. McLeroy, Jordan L. Nelon
Publikováno v:
Evaluation and Program Planning. 73:226-231
Introduction A need for innovative public health programs is evident as the field adapts to address changes in health priorities and target populations. The Innovative Teen Pregnancy Prevention Program (iTP3) was created to support and enable innovat
Autor:
Kim Schadt, Jeffrey W. Sherman, Tom Vescio, Lauren A. Hauser, Julie Ball, Ashley McCormick, S. H. Subramony, Jennifer M. Farmer, Yi Na Dong, Renee Perdok, Susan Perlman, Katherine D. Mathews, Shana E. McCormack, Amy Y. Grahn, David A. Lynch, Alicia Brocht, McKenzie Wells
Publikováno v:
Annals of Clinical and Translational Neurology. 6:546-553
Objective In vitro, in vivo, and open-label studies suggest that interferon gamma (IFN-γ 1b) may improve clinical features in Friedreich Ataxia through an increase in frataxin levels. The present study evaluates the efficacy and safety of IFN-γ 1b
Publikováno v:
Archives of Public Health, Vol 80, Iss 1, Pp 1-13 (2022)
Background Teen pregnancy prevention in the United States has traditionally focused on the development, testing, and subsequent implementation of a set of evidence-based programs (EBPs), recommended nationally. However, these existing EBPs often do n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5d5e4694dd7ee68c24411587077110a
https://doi.org/10.21203/rs.3.rs-450503/v1
https://doi.org/10.21203/rs.3.rs-450503/v1
Autor:
Lauren A. Hauser, Marek Napierala, Amanda Clark, Jennifer M. Farmer, Kimal Rajapakshe, David A. Lynch, Peining Xu, Clementina Mesaros, Dean P. Edwards, Yu-Yun Chen, Ian A. Blair, Shixia Huang, Cristian Coarfa, Jill S. Napierala
Publikováno v:
Molecular & Cellular Proteomics : MCP
Identifying biomarkers is important for assessment of disease progression, prediction of symptom development, and determination of treatment effectiveness. While unbiased analyses of differential gene expression using next-generation sequencing metho
Autor:
Theresa A. Zesiewicz, Mary Danoudis, Sarah C Milne, Ritchie Malapira, Jane Larkindale, Geneieve Tai, Tyagi Ramakrishnan, Nellie Georgiou-Karistianis, Seok Hun Kim, Jessica D. Shaw, Fatemeh Rasouli, Louise A. Corben, Eppie M. Yiu, Anna Murphy, Jennifer M. Farmer, Martin B. Delatycki
ObjectiveTo identify gait and balance measures that are responsive to change during the timeline of a clinical trial in Friedreich ataxia (FRDA) we administered a battery of potential measures three times over a 12-month period.MethodsSixty-one ambul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45e6b7a403d63c51fd8dd55097a0ff46
https://doi.org/10.1101/2021.03.18.434657
https://doi.org/10.1101/2021.03.18.434657